XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (7801)	11/24/1998 11:16:00 AM
From: Bluegreen	Read Replies (2) of 17367

George, it says move is in anticipation of approval of Neuprex. I concentrate on the reason given for the move. I'm sure there are arguments on both sides but how does Xoma justify? It states CLEARLY: IN ANTICIPATION OF APPROVAL OF NEUPREX. Doesn't Xoma know of how many deaths in Meningo. trial? Weren't they just asked not to release that info to public? Wouldn't that give them a hint? When I see a bold move like this and statements of anticipatory nature, well that may not be enough for some but to me this is a no brainer on their confidence along with ramping up of employees. George, just in my opinion, but at this stage of a biotech, it doesn't get any better than this.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next